4/A//SEC Filing
Sherman Darren 4/A
Accession 0001213900-23-041609
CIK 0001814114other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:38 PM ET
Size
9.7 KB
Accession
0001213900-23-041609
Insider Transaction Report
Form 4/AAmended
Sherman Darren
DirectorSee Remarks
Transactions
- Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+116,250→ 116,250 totalExercise: $10.00Exp: 2033-01-19→ Common Stock (116,250 underlying) - Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+508,397→ 508,397 totalExercise: $10.00Exp: 2032-08-17→ Common Stock (508,397 underlying)
Footnotes (5)
- [F1]On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration dates of two classes of nonstatutory stock options ("NSOs") and (ii) misstated the vesting schedules for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration dates in Table II, Column 6 to August 17, 2032 and January 19, 2033, respectively, and (ii) correct the incorrect vesting schedules set forth in the footnotes corresponding to such NSOs, which are reproduced in this amendment with the correct vesting schedules; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.
- [F2]The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with September 30, 2022, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022.
- [F3]Received in the Business Combination in exchange for a nonstatutory stock option to acquire 1,093,327 shares of Legacy Orchestra Common Stock for $4.65 per share.
- [F4]The NSOs vest over a three-year period as follows: (i) 44.4% of the underlying shares vested on the grant date and (ii) 55.6% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting with March 31, 2023, subject to the Reporting Person's continuous service through such dates. The grant date is January 20, 2023.
- [F5]Received in the Business Combination in exchange for a nonstatutory stock option to acquire 250,000 shares of Legacy Orchestra Common Stock for $4.65 per share.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001723524
Filing Metadata
- Form type
- 4/A
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:38 PM ET
- Size
- 9.7 KB